These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 10861924

  • 1. Treatment for Alzheimer's disease.
    Wilcock GK.
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract] [Full Text] [Related]

  • 2. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D.
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract] [Full Text] [Related]

  • 3. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM, Farlow MR.
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract] [Full Text] [Related]

  • 4. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
    Schwalbe O, Wunderlich S, Kloft C.
    Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
    [Abstract] [Full Text] [Related]

  • 5. [Medical treatment of Alzheimer's disease].
    Andersen SE.
    Ugeskr Laeger; 2006 Oct 30; 168(44):3833; author reply 3833. PubMed ID: 17131519
    [No Abstract] [Full Text] [Related]

  • 6. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O.
    J Am Geriatr Soc; 2008 May 30; 56(5):946-7. PubMed ID: 18454755
    [No Abstract] [Full Text] [Related]

  • 7. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A.
    Lakartidningen; 1996 Jan 03; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract] [Full Text] [Related]

  • 8. Outcomes of Alzheimer's disease treatment: the Italian CRONOS project.
    Bianchetti A, Padovani A, Trabucchi M.
    Int J Geriatr Psychiatry; 2003 Jan 03; 18(1):87-8. PubMed ID: 12497562
    [No Abstract] [Full Text] [Related]

  • 9. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM, Boomkamp-Snoeren CM, van Puijenbroek E, Jansen PA, van Marum RJ.
    Tijdschr Gerontol Geriatr; 2009 Apr 03; 40(2):79-84. PubMed ID: 19472574
    [Abstract] [Full Text] [Related]

  • 10. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R.
    MMW Fortschr Med; 2002 May 06; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [Abstract] [Full Text] [Related]

  • 11. [Post-marketing observational study of donepezil].
    Ibach B.
    Krankenpfl J; 2005 May 06; 43(1-3):25. PubMed ID: 15912820
    [No Abstract] [Full Text] [Related]

  • 12. Donepezil for Alzheimer's disease.
    Benjamin B, Burns A.
    Expert Rev Neurother; 2007 Oct 06; 7(10):1243-9. PubMed ID: 17939763
    [Abstract] [Full Text] [Related]

  • 13. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW, Yik PY, Mok W, Chung CP.
    Int J Clin Pract; 2007 Mar 06; 61(3):403-10. PubMed ID: 17313606
    [Abstract] [Full Text] [Related]

  • 14. The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease.
    Zarowitz BJ, Stefanacci R, Hollenack K, O'Shea T, Gruber J, Tangalos EG.
    J Am Med Dir Assoc; 2007 Mar 06; 8(3):183-93. PubMed ID: 17349948
    [No Abstract] [Full Text] [Related]

  • 15. Cognition-enhancing drugs in dementia: a guide to the near future.
    van Reekum R, Black SE, Conn D, Clarke D.
    Can J Psychiatry; 1997 Jun 06; 42 Suppl 1():35S-50S. PubMed ID: 9220128
    [Abstract] [Full Text] [Related]

  • 16. Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Homma A, Brodaty H, Bruno G, Cummings JL, Gilman S, Gracon S, McKeith IG.
    Alzheimer Dis Assoc Disord; 1997 Jun 06; 11 Suppl 3():54-5. PubMed ID: 9305518
    [No Abstract] [Full Text] [Related]

  • 17. Advances in the treatment of Alzheimer's disease.
    Schneider LS.
    Aging (Milano); 1998 Apr 06; 10(2):156-7. PubMed ID: 9666210
    [No Abstract] [Full Text] [Related]

  • 18. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT, Edwards KR, Zhao Q.
    J Clin Pharmacol; 2006 Jul 06; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [Abstract] [Full Text] [Related]

  • 19. Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome.
    Prasher VP, Fung N, Adams C.
    Int J Geriatr Psychiatry; 2005 May 06; 20(5):496-7. PubMed ID: 15852458
    [No Abstract] [Full Text] [Related]

  • 20. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A.
    Neuropsychiatr; 2007 May 06; 21(3):230-3. PubMed ID: 17915184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.